Local Institution

Orlando, Florida 32825

0 studies enrolling now · 19 studies all time

What they study most

AIDS, Acute Coronary Syndromes, Bipolar Disorder, Breast Cancer, Cancer, Diabetes Mellitus, Diabetes Mellitus II, Diabetes Mellitus, Type 2, HIV Infections, Hepatitis C Virus, Major Depressive Disorder, Metastases

Studies at this site

• Pan Tumor Rollover Study — Recruiting now
• A Study of Adjunctive Aripiprazole in Participants With Major Depressive Disorder — Completed
• A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment — Completed
• Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus — Completed
• A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects — Completed
• Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis C — Withdrawn before enrolling
• Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode — Completed
• A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder — Completed
• PPAR - Combination With Metformin — Completed
• BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada — Completed
• Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) — Completed
• DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy — Completed
• A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors — Completed
• A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen — Completed
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed
• Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen — Completed
• A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen — Completed